Assignee
AMBROS PHARMA S R L
IT·3 granted patents·1 pending application·53 citations·filing 2000–2017
Top patents by PatentIndex Score
4 records- 0189US7670619B2Controlled-release formulations containing tryptophan or its metabolitesAMBROS PHARMA S R L·Filed 2005·Granted Mar 2, 2010·31 cites·14 claims
- 0286US7858656B2Controlled release formulations containing an active ingredient, preferably melatonin and the method of preparationAMBROS PHARMA S R L·Filed 2007·Granted Dec 28, 2010·13 cites·9 claims
- 0372US6447818B1Compositions containing compounds with adrenergic activity and vegetable extracts of Crataegus and gingko biloba for the treatment of overweight and obesityAMBROS PHARMA S R L·Filed 2000·Granted Sep 10, 2002·9 cites·17 claims
- 0439US2017165232A1Three-phase controlled-release tablet comprising melatonin and process of preparationAMBROS PHARMA S R L·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMBROS PHARMA S R L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →